Pegylated Interferon (Alone or With Ribavirin) for Chronic Hepatitis C in Haemodialysis Population

Pegylated Interferon (Alone or With Ribavirin) for Chronic Hepatitis C in Haemodialysis Population

Background/Aims: Hepatitis C virus infection remains prevalent among patients undergoing long-term haemodialysis and has a detrimental impact on survival in this population. Antiviral therapy for chronic hepatitis C in haemodialysis patients is still a challenge to clinicians. The aim of the current...

Full description

Bibliographic Details
Main Authors: Mario Espinosa, Jesùs Hernàndez, Maria Dolores Arenas, Fernando Carnicer, Carlos Caramelo, Fabrizio Fabrizi
Format: Article
Language:English
Published: Karger Publishers 2015-05-01
Series:Kidney & Blood Pressure Research
Subjects:
Chronic kidney disease
Dialysis
Hepatitis C
Pegylated interferon
Ribavirin
Online Access:http://www.karger.com/Article/FullText/368501

Internet

http://www.karger.com/Article/FullText/368501

Similar Items